Prosecution Insights
Last updated: August 16, 2026
Application No. 18/492,611

THERMOPLASTIC STARCH FORMULATIONS WITH ADDITIVES FOR PERFORMANCE ENHANCEMENTS

Non-Final OA §103
Filed
Oct 23, 2023
Priority
Oct 24, 2022 — provisional 63/418,852 +2 more
Examiner
LEE, DORIS L
Art Unit
1764
Tech Center
1700 — Chemical & Materials Engineering
Assignee
BIOLOGIQ, INC.
OA Round
1 (Non-Final)
59%
Grant Probability
Moderate
1-2
OA Rounds
3m
Est. Remaining
67%
With Interview

Examiner Intelligence

Grants 59% of resolved cases
59%
Career Allowance Rate
627 granted / 1070 resolved
-6.4% vs TC avg
Moderate +9% lift
Without
With
+8.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
40 currently pending
Career history
1117
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
57.7%
+17.7% vs TC avg
§102
15.2%
-24.8% vs TC avg
§112
13.7%
-26.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1070 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I (claims 1-14) in the reply filed on June 8, 2026 is acknowledged. Claims 15-21 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. The requirement is deemed proper and is therefore made FINAL. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-6 and 11-14 is/are rejected under 35 U.S.C. 103 as being unpatentable over LaPray et al (US 2019/0276664) in view of Ueda et al (US 2008/0036115). Regarding claims 1, 4-6, and 11-13, LaPray teaches a thermoplastic starch-based material formed from: a starch ([0051]) in the amount from 65 to 95 % by weight ([0051)] a plasticizer ([0054]) in the amount from 12 to 35 % by weight ([0053]) a thermoplastic resin such as a polylactic acid ([0041]) It is noted that the diglycidyl ether is not mandatorily present. LaPray teaches that a compatibilizer can be added to the composition ([0085]), however fails to teach the addition of a diacid or corresponding acid anhydride in the amount from 0.1 to 15 % by weight ([0033]) Ueda teaches a thermoplastic (PLA) ([0020]) and starch material ([0021]). Ueda incorporates a compatibilizer such as maleic acid or maleic anhydride ([0033]). It would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to have the maleic acid/anhydride of Ueda be the compatibilizer of LaPray. One would have been motivated to do so in order to receive the expected benefit of improving the mechanical strength of the molded object (Ueda, [0034]). Regarding claims 2-3, LaPray teaches that the plasticizer can be sorbitol ([0054]), and while glycerin is mentioned in [0054]), it is not mandatorily present, and therefore, the composition can be free from glycerin. Regarding claim 14, LaPray teaches that the composition contains less than 1 % by weight water ([0054]) and this would be from any component in the composition. Claim(s) 7-10 is/are rejected under 35 U.S.C. 103 as being unpatentable over LaPray et al (US 2019/0276664) in view of Ueda et al (US 2008/0036115) and Traugott et al (US 6,403,692). The discussion regarding LaPray and Ueda in paragraph 4 above is incorporated here by reference. Regarding claims 7-10, LaPray fails to teach the addition of a diglycidyl ether. Traugott teaches a thermoplastic composition (Abstract) which incorporates 0.01 to 25 parts by weight (col. 11, lines 25-40) of a diglycidyl ether (col. 11, lines 20-25). It would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to have the diglycidyl ether of Traugott incorporated as an additive of the composition of LaPray. One would have been motivated to do so in order to receive the expected benefit of having ignition resistance properties (Traugott, col. 11, lines 15-30). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to DORIS L LEE whose telephone number is (571)270-3872. The examiner can normally be reached M-F 8 am - 5 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Arrie Lanee Reuther can be reached at 571-270-7026. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. DORIS L. LEE Primary Examiner Art Unit 1764 /DORIS L LEE/Primary Examiner, Art Unit 1764
Read full office action

Prosecution Timeline

Oct 23, 2023
Application Filed
Jul 14, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12703803
LAMINATE INCLUDING SURFACE LAYER HAVING SCRATCH RESISTANCE AND MATTE PROPERTIES AND SURFACE COATING COMPOSITION
3y 3m to grant Granted Aug 11, 2026
Patent 12703784
TIRE TREAD RUBBER COMPOSITION COMPRISING RICE HUSK ASH SILICA
3y 8m to grant Granted Aug 11, 2026
Patent 12698362
SELF-HEALING SILOXANE ELASTOMERS
4y 1m to grant Granted Aug 04, 2026
Patent 12698424
CURRENT COLLECTOR PROTECTIVE GLUE
3y 9m to grant Granted Aug 04, 2026
Patent 12698418
ADHESIVE COMPOSITION, BONDED BODY AND PRODUCTION METHOD FOR AN ADHESIVE COMPOSITION
2y 10m to grant Granted Aug 04, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
59%
Grant Probability
67%
With Interview (+8.6%)
3y 1m (~3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1070 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month